ASH Ashland Global Holdings Inc.

Ashland to host 2025 Innovation Day for analysts and investors

Ashland to host 2025 Innovation Day for analysts and investors

WILMINGTON, Del., March 28, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) is hosting an Innovation Day for analysts and investors at the company’s Bridgewater, New Jersey facility, Thursday, May 29, 2025. The event will showcase the enhanced capabilities and expanded applications of Ashland's scalable technology platforms. Registration is required, with options to attend via live webcast or in person.

Participants will join Ashland’s executive and senior technology team for an in-depth review of the latest developments and their expanding commercial opportunities. The presentations will detail how these advancements are poised to impact key markets and drive future growth.

Following the presentation, participants will have the opportunity to engage directly with Ashland’s senior leadership in a moderated question and answer (Q&A) session. In-person attendees will experience the tangible progress through a lab tour, showcasing the evolved applications across Life Sciences, Personal Care, and Specialty Additives.

Ashland leaders presenting at the event include:

  • Guillermo Novo, chair, and chief executive officer
  • Osama Musa, senior vice president and chief technology officer
  • Dago Caceres, senior vice president and general manager, specialty additives
  • Alessandra Faccin, senior vice president and general manager, life sciences and intermediates
  • Jim Minicucci, senior vice president and general manager, personal care
  • William Whitaker, vice president finance and director investor relations
  • Additional senior members of the technical and commercial teams

Presentations will begin promptly at 9:00 a.m. ET and conclude after the Q&A session at approximately 11:30 a.m. ET. Following the Q&A, in-person attendees will have the opportunity to connect with business line leaders and scientists during a luncheon and a subsequent lab tour, concluding around 2:00 p.m. ET. Due to limited in-person seating, early registration is strongly encouraged. To register, please visit the following link:

Registration information and further event details will be posted on Ashland’s investor website at 

A webcast of the event will be available live and can be accessed, along with supporting materials, through the Ashland website. A replay will be available within 24 hours of the live event and will be archived, along with supporting materials, on Ashland’s website for 12 months. Copies of the presentation may also be requested by sending an email to

About Ashland 

Ashland Inc. (NYSE: ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social and governance (ESG). The company serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care and pharmaceutical. Approximately 3,200 passionate, tenacious solvers – from renowned scientists and research chemists to talented engineers and plant operators – thrive on developing practical, innovative and elegant solutions to complex problems for customers in more than 100 countries. Visit  and to learn more.  

Trademark, Ashland or its subsidiaries, registered in various countries.

FOR FURTHER INFORMATION:

Investor Relations:Media Relations:
William C. Whitaker Carolmarie C. Brown
+1 (614) 790-2095+1 (302) 995-3158

Attachment



EN
28/03/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ashland Global Holdings Inc.

 PRESS RELEASE

Ashland expands pharmaceutical plant for Aquarius™ tablet coatings and...

Ashland expands pharmaceutical plant for Aquarius™ tablet coatings and commissions new microbial protection capability in Brazil, demonstrating strategy to globalize, innovate, and invest Increased production capacity and market presence expected to drive competitive position and organic growth; follows previous investments in Ireland and China Wilmington, Del., April 01, 2025 (GLOBE NEWSWIRE) -- Ashland has completed a 10-million-dollar expansion of its pharmaceutical manufacturing plant in Cabreúva, Brazil and will celebrate the occasion with a ribbon-cutting ceremony on April 4, 202...

 PRESS RELEASE

Ashland to host 2025 Innovation Day for analysts and investors

Ashland to host 2025 Innovation Day for analysts and investors WILMINGTON, Del., March 28, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) is hosting an Innovation Day for analysts and investors at the company’s Bridgewater, New Jersey facility, Thursday, May 29, 2025. The event will showcase the enhanced capabilities and expanded applications of Ashland's scalable technology platforms. Registration is required, with options to attend via live webcast or in person. Participants will join Ashland’s executive and senior technology team for an in-depth review of the latest developments an...

 PRESS RELEASE

Ashland completes sale of Avoca business to Mane

Ashland completes sale of Avoca business to Mane Wilmington, Del., March 17, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) announced today that it has completed the sale of its Avoca business to Mane effective March 14, 2025. Financial terms of the transaction were not disclosed. The Avoca business supplies sclareolide, a fragrance fixative, and a range of contract manufacturing capabilities from two production facilities in North Carolina and Wisconsin.  The Avoca business line represents the last entity from Ashland’s previous acquisition of Pharmachem. “The Avoca business is a s...

Ashland Inc: 2 directors

Two Directors at Ashland Inc bought/maiden bought 34,444 shares at between 64.000USD and 64.240USD. The significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directo...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch